--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Meta Platforms
META
Adobe
ADBE
US Stock MarketDetailed Quotes
GALT Galectin Therapeutics
- 1.150
- +0.280+32.17%
Close Dec 27 16:00 ET
- 1.120
- -0.030-2.61%
Post 19:57 ET
72.18MMarket Cap-1.58P/E (TTM)
1.470High0.901Low5.98MVolume0.901Open0.870Pre Close7.26MTurnover13.63%Turnover RatioLossP/E (Static)62.76MShares4.26852wk High-0.76P/B50.49MFloat Cap0.72652wk Low--Dividend TTM43.91MShs Float38.280Historical High--Div YieldTTM65.40%Amplitude0.300Historical Low1.213Avg Price1Lot Size
Galectin Therapeutics Key Stats
Galectin Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Galectin Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
